| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |